The discovery of novel 5,6,5-and 5,5,6-tricyclic pyrrolidines as potent and selective DPP-4 inhibitors

被引:17
作者
Cox, Jason M. [1 ]
Chu, Hong D. [1 ]
Kuethe, Jeffrey T. [1 ]
Gao, Ying-Duo [5 ]
Scapin, Giovanna [5 ]
Eiermann, George [2 ]
He, Huaibing [4 ]
Li, Xiaohua [4 ]
Lyons, Kathryn A. [4 ]
Metzger, Joseph [3 ]
Petrov, Aleksandr [2 ]
Wu, Joseph K. [3 ]
Xu, Shiyao [4 ]
Sinha-Roy, Ranabir [3 ]
Weber, Ann E. [1 ]
Biftu, Tesfaye [1 ]
机构
[1] Merck Res Labs, Dept Chem, 2015 Galloping Hill Rd, Kenilworth, NJ 07033 USA
[2] Merck Res Labs, Dept Pharmacol Screening & Prot Sci, 2015 Galloping Hill Rd, Kenilworth, NJ 07033 USA
[3] Merck Res Labs, Dept Cardiometab Dis, 2015 Galloping Hill Rd, Kenilworth, NJ 07033 USA
[4] Merck Res Labs, Dept PPDM, 2015 Galloping Hill Rd, Kenilworth, NJ 07033 USA
[5] Merck Res Labs, Dept Struct Chem, 2015 Galloping Hill Rd, Kenilworth, NJ 07033 USA
关键词
Dipeptidyl peptidase IV (DPP-4); Type 2 diabetes mellitus; Sitagliptin; Omarigliptin; RATIONAL DESIGN; PEPTIDASE; HOMOLOG; BIOLOGY; ANALOGS;
D O I
10.1016/j.bmcl.2016.04.020
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Novel potent and selective 5,6,5- and 5,5,6-tricyclic pyrrolidine dipeptidyl peptidase IV ( DPP-4) inhibitors were identified. Structure-activity relationship ( SAR) efforts focused on improving the intrinsic DPP-4 inhibition potency, increasing protease selectivity, and demonstrating clean ion channel and cytochrome P450 profiles while trying to achieve a pharmacokinetic profile suitable for once weekly dosing in humans. (C) 2016 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2622 / 2626
页数:5
相关论文
共 22 条
  • [1] Cloning, expression and chromosomal localization of a novel human dipeptidyl peptidase (DPP) IV homolog, DPP8
    Abbott, CA
    Yu, DMT
    Woollatt, E
    Sutherland, GR
    McCaughan, GW
    Gorrell, MD
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 2000, 267 (20): : 6140 - 6150
  • [2] [Anonymous], 2013, IDF DIABETES ATLAS
  • [3] Biology of incretins: GLP-1 and GIP
    Baggio, Laurie L.
    Drucker, Daniel J.
    [J]. GASTROENTEROLOGY, 2007, 132 (06) : 2131 - 2157
  • [4] Omarigliptin (MK-3102): A Novel Long-Acting DPP-4 Inhibitor for Once-Weekly Treatment of Type 2 Diabetes
    Biftu, Tesfaye
    Sinha-Roy, Ranabir
    Chen, Ping
    Qian, Xiaoxia
    Feng, Dennis
    Kuethe, Jeffrey T.
    Scapin, Giovanna
    Gao, Ying Duo
    Tan, Youwei
    Krueger, Davida
    Bak, Annette
    Eiermann, George
    He, Jiafang
    Cox, Jason
    Hicks, Jacqueline
    Lyons, Kathy
    He, Huaibing
    Salituro, Gino
    Tong, Sharon
    Patel, Sangita
    Doss, George
    Petrov, Aleksandr
    Wu, Joseph
    Xu, Shiyao Sherrie
    Sewall, Charles
    Zhang, Xiaoping
    Zhang, Bei
    Thornberry, Nancy A.
    Weber, Ann E.
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (08) : 3205 - 3212
  • [5] Novel tetrahydropyran analogs as dipeptidyl peptidase IV inhibitors: Profile of clinical candidate (2R,3S,5R)-2-(2,5-difluorophenyl)-5-[2-(methylsulfonyl)-2,6-dihydropyrrolo[3,4-c]pyrazol-5(4H)-yl]tetrahydro-2H-pyran-3-amine (23)
    Biftu, Tesfaye
    Qian, Xiaoxia
    Chen, Ping
    Feng, Dennis
    Scapin, Giovanna
    Gao, Ying-Duo
    Cox, Jason
    Roy, Ranabir Sinha
    Eiermann, George
    He, Huabing
    Lyons, Kathy
    Salituro, Gino
    Patel, Sangita
    Petrov, Alexander
    Xu, Feng
    Xu, Shiyao Sherrie
    Zhang, Bei
    Caldwell, Charles
    Wu, Joseph K.
    Lyons, Kathy
    Weber, Ann E.
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (19) : 5361 - 5366
  • [6] Rational design of a novel, potent, and orally bioavailable cyclohexylamine DPP-4 inhibitor by application of molecular modeling and X-ray crystallography of sitagliptin
    Biftua, Tesfaye
    Scapin, Giovanna
    Singh, Suresh
    Feng, Dennis
    Becker, Joe W.
    Eiermann, George
    He, Hualbing
    Lyons, Kathy
    Patel, Sangita
    Petrov, Aleksandr
    Sinha-Roy, Ranabir
    Zhang, Bei
    Wu, Joseph
    Zhang, Xiaoping
    Doss, George A.
    Thornberry, Nancy A.
    Weber, Ann E.
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (12) : 3384 - 3387
  • [7] Minireview: Update on Incretin Biology: Focus on Glucagon-Like Peptide-1
    Brubaker, Patricia L.
    [J]. ENDOCRINOLOGY, 2010, 151 (05) : 1984 - 1989
  • [8] Structure-activity-relationship of amide and sulfonamide analogs of omarigliptin
    Chen, Ping
    Feng, Dennis
    Qian, Xiaoxia
    Apgar, James
    Wilkening, Robert
    Kuethe, Jeffrey T.
    Gao, Ying-Duo
    Scapin, Giovanna
    Cox, Jason
    Doss, George
    Eiermann, George
    He, Huaibing
    Li, Xiaohua
    Lyons, Kathryn A.
    Metzger, Joseph
    Petrov, Aleksandr
    Wu, Joseph K.
    Xu, Shiyao
    Weber, Ann E.
    Yan, Youwei
    Roy, Ranabir Sinha
    Biftu, Tesfaye
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2015, 25 (24) : 5767 - 5771
  • [9] Cox J. M., PCT Int. Appl., Patent No. [WO2008060488 A1, 2008060488]
  • [10] Cox J. M., 2012, 33 NAT MED CHEM S TU